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Abstract
Despite the considerable progress that has been made in radiotherapy in recent years, the side effects of ionising radiation 
treatment still constitute a major therapeutic problem on account of the multi-sidedness of the complications involved. 
The objective of the study was to determine the clinical condition of patients and the presence of fungi in the patients 
before, during and after radiotherapy, and on this basis prepare guidelines for local dental treatment as a recommended 
procedure for supporting cancer treatment. A total of 82 patients were treated for cancers of the head and neck organs 
with radiotherapy. The clinical condition of the oral cavity was assessed as was the appearance of fungi (a qualitative and 
quantitative assessment) in patients prior to the beginning of treatment, during treatment (weeks 2 and 4 of treatment), 
as well as after its conclusion. The sensitivity of selected strains of fungi to anti-fungal drugs was also assessed using the 
ATB Fungus method. During the course of the radiotherapy the condition of patients deteriorated significantly, especially 
in week 4 of the treatment, which was confirmed by mycological tests and the appearance of symptoms of oral mucositis. 
Assessments of fungal abundance (intensiveness) of fungi at particular stages of the study illustrates the dynamic of the fungal 
process. Results: 1) the use of radiotherapy has side effects which have a negative impact on the oral capacity of patients, 
i.e. inflammation of the mucous membrane (oral mucositis) and the appearance of erosion and ulceration; 2) simultaneously, 
the level of yeast-like fungi increases and candidiasis develops; 3) bacterial and fungal infections, as well as increasing acute 
post-radiation reaction in the mucous membranes of head and neck organs, requires prophylaxis and dental treatment.
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IntroductIon
Urbanisation, a longer life expectancy and specific lifestyle 
factors (habits and addictions) have led to an increase in the 
number of patients suffering from cancer. Each year, 11 million 
people worldwide are diagnosed with malignant tumours, 
almost 7 million of whom die as a result (epidemiological 
data from WHO, EU, NCI from 2005). Some 120,000 new 
cases of the disease are reported in Poland each year, of which 
85,000 are terminal. According to the European Society for 
Medical Oncology, in Poland malignant tumours of the oral 
cavity and the throat account for 6% of all cancer patients 
each year, and the five-year survival rate is 23.3% for men 
and approximately 40% for women [1].
Alongside surgery, radiotherapy is one of the traditional 
methods used to treat malignant tumours of the head and 
neck, and according to estimates is administered in various 
forms in around 50% of patients. Radiotherapy plays an 
important role in the treatment of patients with cancers in 
this region of the body since its effectiveness is comparable 
with surgical treatment, and, moreover, it makes it possible 
to save the organ affected by the cancer, thereby preventing 
the patient from suffering permanent mutilation.
The main issue of importance during radiotherapy of 
cancers of the head and neck are lesions resulting from 
acute radiation damage, i.e. inflammation of the mucous 
membrane, otherwise known as oral mucositis [2, 3]. A 
number of factors have a major effect on the development 
and intensification of oral mucositis, including the type of 
radiation administered, the way the dose is fractionated, and 
the cumulative dosage. Severe post-radiation oral mucositis 
occurs in all patients with cancers in this region who have 
undergone conventional radiation treatment, i.e. a dose of 
60-70 Gy administered in 30-35 fractions over a period of 6-7 
weeks. This leads to the onset of secondary infections (mainly 
fungal) often accompanied by pain, which can prevent the 
consumption of solids and liquids. Some patients then even 
require a dosage of narcotic pain killers. The most intense 
pain appears in areas of non-attached, non-keratinised 
mucous membrane – in the cheeks, soft palate, mucous 
part of the lips, and floor of the mouth [4, 5].
During the course of radiotherapy, damage to the oral 
mucous membrane is caused by fungal growth, most 
commonly in the form of Candida [6, 7, 8]. The principal 
local factors predisposing a patient to the onset of mycosis 
are the following: poor oral hygiene, diminished salivary 
secretion, the wearing of extensive dentures and long-
term inflammation of the mucous membrane. The onset of 
candidiasis in the oral cavity during radiotherapy is usually 
acute in character. The fungi can colonise other sections of 
the alimentary canal, thereby causing inflammation of the 
oesophagus, diarrhea, and also general infection [9, 10]. One 
of the most serious side-effects of radiotherapy is xerostomia, 
which can last for up to many years [11, 12].
Despite the considerable progress made in radiotherapy in 
recent years, the side-effects of such treatment still constitute 
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a major therapeutic problem on account of the many-faceted 
complications. Studies in this area have been conducted not 
only by oncologists and specialists in cancer radiotherapy, 
but also by geneticists, microbiologists, and recently also 
by dentists.
objectIve of the Study
The objective of the study was to determine the clinical 
state and microflora (qualitative and quantitative analysis 
of the fungi) of the oral mucous membrane in patients with 
cancer of the organs of the the head and neck prior to the 
commencement of radiotherapy, during the course of such 
treatment (at weeks 2 and 4 of treatment), as well as 4-6 
weeks after the termination of the radiotherapy, and on 
this basis prepare guidelines for local dental treatment as 
a recommended procedure supporting cancer treatment.
MAterIAl And MethodS
The study method comprised both a clinical part and a 
laboratory part, including microbiological (mycological) 
tests. The cycle covered the following:
– a clinical assessment of the oral mucous membrane 
in patients with cancers of the organs of the head and 
neck (prior to radiation, during the course of radiation – 
during the second and fourth week of treatment, and after 
termination of the treatment);
– determining the frequency of fungal infections, identifying 
isolated fungi and providing a quantitative assessment of 
the abundance of fungal growth (quantitative tests);
– an assessment of the sensitivity of isolated fungi to anti-
fungal drugs;
– establishing a schema for local treatment (depending on 
the clinical condition and state of the oral microflora), and 
administering this treatment to patients both during and 
after termination of the radiotherapy.
A total of 82 patients took part in the study, aged between 
27-81 (average age 58.6±10.7), consisting of 63 men (76.8%) 
aged 27-81 and 19 women (23.2%) aged 35-76, who were being 
treated for cancer of the organs of the head and neck, and who 
underwent primary radiation or post-operative radiation at 
the M. Skłodowska-Curie Memorial Institute of Oncology 
in Krakow. Patients received a radiation dose of 60-70 Gy 
administered in 30-35 fractions over a period of 6-8 weeks.
The most common forms of cancer were cancer of the 
larynx, which was diagnosed in 43.9% of the patients 
(36 patients), cancer of the tonsils, identified in 15.85% of 
cases (13 patients), and nasopharyngeal cancer, which was 
discovered in 7 patients (Fig. 1).
From the total group of 82 patients, 31 who underwent 
radiotherapy (37.8%) came from the countryside, 35 (42.7%) 
were residents mainly of small towns with populations of 
up to 30,000, while 7.3% of the patients (6 persons) lived in 
large cities (Fig. 2).
Of the 82 patients in the study, 90.2% (74 persons) were 
regular smokers (23 of whom had smoked more than 20 
cigarettes a day for more than 30-40 years), and 9.8% were 
non-smokers (8 patients).
27 of the patients drank alcohol excessively (32.9% of 
the respondents). Another 31 patients (37.8%) had had 
contact with harmful substances in the workplace (paints, 
glues, varnishes, etc.), while 50 persons reported suffering 
from high or moderate levels of stress (61% of the patients). 
47 of the patients (31%) had earlier undergone surgery with 
radiotherapy used as supportive therapy. The only treatment 
received by the other patients (35 persons) was ionising 
radiation.
All patients had both an interview and a physical 
examination, which included a clinical assessment of the state 
of the oral cavity, the cancer treatment being administered, 
the results of laboratory tests and the treatment being received.
The clinical examination covered the following cycle of 
tests:
 – prior to radiotherapy (assessment of initial state);
 – in the second week of radiotherapy (an assessment of the 
effects of radiotherapy on the state of the patient’s oral 
cavity);
 – implementation of dental treatment procedure;
 – in the fourth week of radiotherapy and second week of 
dental treatment (an assessment of the effects of supportive 
dental treatment);
 – continuation of dental treatment;
 – final examination i.e. after the termination of the radiation 
treatment and the termination of the supportive dental 
treatment.
The intensity of lesions in the mucous membrane were 
assessed using the 5-point WHO scale:
0 – no symptoms of disease in the oral mucous membrane;
I – erythema of mucous membrane, swelling, soreness in 
oral cavity;
II – erythema of mucous membrane, swelling, surface 
erosion, patient can swallow solid foods;
III – erythema of mucous membrane, swelling, presence of 


















































figure 1. Types of malignant neoplasms
figure 2. Classification of patients based on city size
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IV – erythema of mucous membrane, swelling, ulceration, 
patient fed parenterally.
Smears were taken of the mucous membrane of the right 
cheek together with washings from the oral cavity. The 
mucous membrane smear was taken using a sterile plastic 
wand with a viscose swab, which was applied to the mucosa in 
the established position and rotated 360°. The washing from 
the oral cavity was obtained after instructing the patients 
to rinse their oral cavities with 5 ml of physiological salt for 
30 seconds. The material was collected in a sterile plastic 
container while observing the generally applied rules for 
microbiological tests regarding the time and method used to 
collect the biological material, the volume and amount of the 
samples taken and transported to the microbiological lab. The 
standard of care when working with potentially infectious 
materials was adhered to [13]. The collected clinical material 
was used to carry out mycological tests. To identify the fungi, 
the materials were cultured on a Sabouraud base. The amount 
of fungi was assessed in a 1 ml washing, and the profusion 
of fungi was assessed semi-quantitatively according to the 
following formula:
0 – no fungal growth
1 – slight growth (+): individual colonies (from 1-10 
colonies);
2 – moderate growth (+ +): 11-30 colonies;
3 – abundant growth (+ + +): from 31-100 colonies;
4 – very abundant growth, confluent (+ + + +): above 100 
colonies
All the isolated strains were identified according to the 
methodology applied in mycological diagnostics. The 
sensitivity of the fungi to anti-fungal drugs (5-Fluorocytosine 
(5FC), Amphotericin B (AMB), Fluconazole (FCA), 
Itraconazole (ITR) was assessed using the ATB Fungus 2 
INT [14] test, while their sensitivity to nystatinum (NYS) was 
assessed using the disc-diffusion method. The patients were 
examined and clinical material taken prior to the beginning 
of radiotherapy, in the second week of radiotherapy, in the 
fourth week of treatment, and after the termination of the 
treatment (4-6 weeks).
The results of the clinical and laboratory tests were prepared 
statistically using the software STATISTICA 7.1 and R [15]. 
When testing the hypotheses an error level of α=0.05 was 
adopted. The analysis included tests for non-parametric 
variables: the chi-squared test, a non-parametric variance of 
analysis (AOV) – the Friedman test for associated variables 
and a post-hoc analysis following the Friedman test.
reSultS
For 47 of the 82 patients, radiotherapy constituted 
supplementary treatment for earlier performed surgery. 
Some of these patients reported subjective complications: a 
sensation of burning, tautness and dryness in the oral cavity. 
In the preliminary examination – prior to the commencement 
of radiotherapy – 16 patients (19.5%) reported a burning 
sensation in the oral cavity, and 12 (14.6%) reported tautness 
and dryness in the mucous membrane. In the second week 
of radiotherapy the number of patients reporting a burning 
sensation in the oral cavity had increased to 37 (45.1%), while 
the number reporting the same complications in the fourth 
week of treatment had risen further to 56 (68.3%). These 
complications occurred regardless of the dental treatment the 
patients received. Similarly, the number of persons reporting 
tautness and dryness in the oral cavity also increased. In the 
second week of radiotherapy 44 people (53.7%) complained 
of this complication, and in the fourth week of treatment this 
number had risen to 65 patients (79.3%). An examination 
carried out 4 weeks after the termination of anti-cancer 
therapy showed that dryness of the mucous membrane was 
noted in 20 patients (24.4%) (Fig. 3).
The condition of the mucous membrane prior to 
commencement of radiotherapy and at week 2 and week 4 
of radiotherapy is presented in table I. As the radiotherapy 
continued (week 4), the condition of the patients deteriorated 
significantly and in the majority of patients (85.4%) symptoms 
of oral mucositis were observed with accompanying erosions 
and ulcerations (levels II and III according to the WHO 
scale). Figures 4 and 5 show the clinical changes observed 
at week 4 of the radiotherapy.
A breakdown of fungal growth intensity noted prior to 
the commencement of the treatment, in the second and 
fourth week of treatment and after the termination of the 
treatment is show in Figure 6. Prior to the commencement 
of the radiotherapy, no fungi was cultivated in 44 patients 
(53.7%), while fungi in the form of Candida was assessed 
as slight (+) or moderate (++) in 34 persons (41.5%), and 
abundant growth (+++) was noted in 4 cases. In the second 
week of radiotherapy the number of patients in which no 
fungi was cultivated had declined to 27. On the other hand, 
the number of persons in whom abundant fungal growth was 
noted had risen from 4 to 20 (+++). In week 4 of radiotherapy, 























figure 3. Percentage of patients reporting subjective ailments in the oral cavity in 
particular stages of the radiotherapy. The feeling of dryness and tension of mucous 
in oral cavity have been marked with gray colour; the feeling of burning – has been 
marked with the black colour





Number of patients and percentages
Before 
radiotherapy
In second week  
of treatment
In fourth week  
of treatment
0 70 (85.4%)  0 (0)  0 (0)
I 12 (14.6%) 17 (20.7%) 12 (14.6%)
II  0 (0) 45 (54.9%) 29 (35.4%)
III  0 (0) 20 (24.4%) 41 (50.0%)
IV  0 (0)  0 (0)  0 (0)
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confluent fungal growth (++++), which had not been noted 
earlier in any of the patients in the study, was now observed in 
9 persons (11%). Abundant fungal growth (+++) was observed 
in 18 persons (22%), and moderate growth (++) in another 15 
(18.3%). However, the post hoc test following the Friedman 
analysis revealed no differences in fungal growth intensity 
between the second and fourth weeks of the radiotherapy.
The mycological test, carried out on patients following the 
termination of the ionising radiation treatment, showed no 
fungi cultivation in 54.9% of the patients. In addition, fungal 
growth intensity had returned to the same level observed 
prior to the beginning of the treatment (post hoc test after 
the Friedman analysis at a level of p=0.05). Abundant fungal 
growth (+++) was only noted in 3 persons, moderate fungal 
growth (++) was observed in 15 cases and slight growth (+) 
in another 19.
Figure 7 presents a clinical picture of candidiasis of the 
oral cavity at week 4 of radiotherapy, as confirmed by the 
mycological test (abundant growth- +++).
Table 2 shows the Minimal Inhibitory Concentration 
(MIC) values, determined using the ATB Fungus method, 
of the studied drugs (5-FC, AMB, FCA, ITR) for 84 strains 
of fungi isolated from patients at different stages of the 
treatment. 63 strains belonged to the species C. albicans, 
and 21 strains to the species Candida non-albicans. The Table 
presents the results of the MIC [mg/l] determination in the 
form of the mean, scope and modal value (most frequently 
appearing value) for particular species. Some strains were 
shown to be resistant to fluconazole and itraconazole.
figure 7. Fourth week of radiotherapy. Tongue candidiasis (the presence of Candida 


























before 2nd week 4th week after
figure 5. Fourth week of radiotherapy. Visualization of ulcerations on the palate 
and leucoplakia on the left buccal mucosa. Typical mycotic lesions on the tongue 
(the presence of Candida strains confirmed in mycological examination)
figure 6. The change of the intensity of fungal growth during radiotherapy. On the boxplot chart the line shows median, box – quartile deviation, whiskers – the range 
of data, circles – outliers. (Only those patients, who had the growth of fungi at any stage of treatment stated, have been analysed). On the left side – the intensity of 
fungal growth in particular stages, shown by the percentage of the isolates in the given group
figure 4. Fourth week of radiotherapy. Visualization of the lesions on palate and 
ulceration on the right buccal mucosa
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The sensitivity of the 63 strains of C. albicans to 5 anti-
fungal drugs (AMB, 5-FC, FCA, ITR and NYS) is assessed in 
Table 3. All strains turned out to be sensitive to amphotericin 
B and 5-fluorocytozine, while in the case of nystatinum, 
62 strains were shown to be sensitive, and only 1 showed 
average sensitivity. On the other hand, 38 strains (60.3%) 
were shown to be resistant to itraconazole and 21 strains 
(33.3%) to fluconazole.
dIScuSSIon
The results of the presented study are in accordance with 
data from the literature on the onset and course of oral 
mucositis [16]. In the second week of radiotherapy, more than 
half of the patients (45 persons) suffered acute post-radiation 
mucosal reaction. A clinical examination confirmed swelling 
and reddening of the mucous membrane. Changes were also 
observed in the form of erosions, sometimes covered with 
a fibrous deposit. The patients complained of complications 
affecting the mucous membrane – a feeling of tautness and 
burning, pain brought on by the lesions and reduced saliva 
secretion. The above-dsescribed symptoms mainly occurred 
at night. The patients also reported taste disturbances. In 
week four of the radiation treatment, the condition of the 
patients deteriorated significantly, and in the majority of 
cases (70 persons) symptoms of acute post-radiation mucosal 
reaction (stages II and III according to the WHO scale) were 
observed. Increasing pain and xerostomia (reduced saliva 
secretion) not only impeded the consumption of solid foods 
but made actual eating impossible. Patients could only be fed 
in liquid or semi-liquid form.
The MIC values symptoms described above of oral 
mucositis, as well as the complications connected with it, 
are a consequence of the direct effects of ionising radiation, 
as well as of reduced saliva secretion and changes in the 
composition of the patient’s saliva – a higher concentration 
of electrolytes, greater density, reduction in pH and a 
decline in the concentration of immunoglobulin type A. 
Also not without significance were the patient’s hygiene 
habits. Some authors believe that the patient’s failure to 
observe oral hygiene is caused by depression resulting from 
the diagnosis of cancer, as well as by additional pain and 
soreness originating from the mucous membrane [17, 18].
Similar observations were made and described by the 
authors Carl & Emrich [19], who examined 98 patients who 
had undergone radiotherapy for oral cancer, receiving a dose 
of more than 50 Gy during the course of the treatment. The 
patients in the study had second and third degree mucosal 
inflammation of the oral cavity (according to the three-
degree scale used by the authors).
A study conducted by Grötz et al. [20], and confirmed by 
both Almståhl et al. and Thaweboon et al. [21, 22], shows 
that mycosis is a typical infection of the mucous membrane 
occurring during radiotherapy for head and neck cancers. 
Other authors observed that systemic disorders primarily 
brought on by cancer, radiation and antibiotic treatment 
create suitable conditions for the onset of oral candidiasis [23, 
24, 25]. The Polish literature includes a number of studies that, 
just like the presented study, confirm the appearance of fungi, 
especially in the form of type C. albicans, in the oral cavity of 
cancer patients [26, 27]. A longitudinal study carried out in 
our centre comprising a period of around 2 months for every 
patient showed that Candida albicans fungus predominates 
at all stages of the study. In weeks 2 and 4 of radiotherapy 
the number of patients with oral fungi increased (at week 
2-67.1%, and at week 4-69.5%). On the other hand, the 
number of patients with fungi present in the oral cavity prior 
to treatment was similar to the number with fungi after the 
treatment was completed (prior to radiotherapy: 38 persons 
– 46.3%, after termination of therapy: 37 persons – 45.1%).
The methods used to treat this group of patients (in 
particular radiotherapy and/or chemotherapy) disturb the 
proper functioning of the immune and haemopoietic systems, 
which has a negative effect on oral health. Fungal foci in the 
oral cavity can provide a source of further invasions, and as 
a consequence can cause multifocal candidiasis, as well as 
recurrent mycosis of other organs [28].
The presented study showed that a high percentage of 
strains are resistant to imidazole drugs (33.3% of strains 
were resistant to fluconazole, 60.3% of strains were resistant 
to itraconazole) while at the same time remaining sensitive 
to AMB, 5-FC and NYS. The increased resistance to drugs 
from the imidazole group is becoming an increasingly 
serious clinical problem because these drugs, due to their 
table 3. The susceptibility of 63 Candida albicans strains
AMB 5-FC FCA ITR NYS
S 63 100% 63 100% 39 61.9% 23 36.5% 62 98.4%
I  0   0%  0   0%  3  4.8%  2  3.2%  1  1.65
R  0   0%  0   0% 21 33.3% 38 60.3%  0  0%
S – sensitive, I – intermediate, R – resistant
table 2. MIC values of the drugs tested to 84 strains (mg/l)
Species n 5-fc  AMb  fcA  Itr
Mn R Md Mn  R Md Mn  R Md Mn  R Md
C. albicans 63 0.5 - 0.5 0.5 - 0.5 44.2 0.25-128 128 2.1 0.125-4 4
C. glabrata 5 3.5 0.5-8 0.5 0.5 - 0.5 34.5 0.25-128 none 0.825 0.125-2 0.5
C. kefyr 3 0.5 - 0.5 0.5 - 0.5 0.42 0.25-0.5 0.5 0.125 - 0.125
C. krusei 4 2.7 2-4 2 0.5 - 0.5 13.3 8-16 16 0.375 0.125-0.5 0.25
C. lusitaniae 3 0.5 - 0.5 0.5 - 0.5 2.2 0.5-4 none 0.42 0.125-1 0.125
C. pseudotropicalis 1 0.5 - 0.5 0.5 - 0.5 0.25 - 0.25 0.25 - 0.25
C. tropicalis 5 0.5 - 0.5 0.5 - 0.5 68 8-128 none 3.25 1-4  4
MIC – minimal inhibitory concentration
5-FC – 5-fluorocytosine, AMB – amphotericin B, FCA – fluconazole, ITR – itraconazole
Mn – mean, R – range, Md – modal
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pharmacodynamics and limited undesired effects, are popular 
among doctors and widely recommended. In particular, the 
long-term administration of fluconazole can lead to higher 
induced resistance. Other authors [29] have also observed 
the increasing resistance of strains of Candida fungi, in 
particular Candida non-albicans, to imidazole drugs. When 
fluconazole treatment is unsuccessful, nystatinum proved 
to be effective in the presented study, which has also been 
confirmed by studies on the sensitivity to this drug in vitro.
In turn, a comparative study on the sensitivity of fungi to 
fluconazole and voriconazole [30] covered 79 strains of C. 
glabrata isolated from the oral cavity of patients who had 
earlier undergone radiotherapy for cancer of the head and 
neck. The sensitivity of these strains to the above 2 drugs was 
assessed using the quantitative method NCCLS M27-A2. The 
study showed that both drugs had high MIC values, including 
a higher MIC value for voriconazole, and the MIC value for 
fluconazole was even higher.
The condition of the oral mucous membrane not only 
depends on the total dose of radiation administered, but also 
on the state of the patient’s dentition and mucous membrane 
prior to the beginning of the treatment. It is extremely 
important that every patient referred for radiotherapy has 
undergone a full, radical hygienisation of the oral cavity with 
the aim of eliminating potential infection foci. Treatment 
of oral complications resulting from ongoing or completed 
ionising radiation should be planned and organised for each 
patient individually.
A number of foreign studies have focused on the issue of 
dental care and the problem of properly preparing the patient 
for radiotherapy. Our own observations show that many 
patients begin radiation treatment without undergoing any 
oral rehabilitation or hygienisation procedures. As earlier 
results have confirmed, this intensifies the side-effects, which 
in turn significantly increases the pain experienced by these 
patients.
Based on an analysis of the results of studies conducted 
with the framework of the presented paper, the author 
proposes an algorithm for supportive dental treatment for 
patients undergoing radiotherapy for cancers of the head and 
neck region, which would be divided into the following tasks:
Period I – prior to the commencement of radiotherapy:
 – oncological-dental consultation;
 – elimination of potentially active dentogenic infection foci;
 – removal of active and secondary caries foci, as well as the 
placement of dental fillings;
 – performance of professional hygienisation procedures;
 – instructions in oral hygiene to be observed by the patient;
 – elimination of trauma factors affecting the periodontium 
and soft tissue in the oral cavity, as well as prosthetic 
restorations;
 – recommendations for correct diet.
Period II – during radiotherapy:
 – further co-operation between dentist and oncologist;
 – application of preparations designed to moderate the 
effects of oral mucositis;
 – treatment of local lesions in the oral mucous membrane 
through the application of mycological treatment and/or 
anti-bacterial treatment;
 – elimination or moderation of xerostomia symptoms;
 – motivating patient to observe oral hygiene.
Period III – following the termination of radiotherapy:
 – continuation of collaboration with patient;
 – motivating patient to maintain proper oral hygiene;
 – elimination of existing side-effects of ionising radiation 
treatment (xerostomia, candidiasis, bacterial infections) 
through the continuation of the targeted therapy.
concluSIonS
1. The use of radiotherapy has side-effects which have 
a negative impact on the oral cavity of patients, i.e. 
inflammation of the mucous membrane (oral mucositis) 
and the occurrence of erosion or ulceration.
2. Simultaneously, the level of yeast-like fungi increases and 
candidiasis develops.
3. Bacterial and fungal infections, as well as increasing acute 
post-radiation fungal reaction in the mucous membranes 
of the head and neck organs, require prophylaxis and 
dental treatment.
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